Phase I and pharmacologic study of paclitaxel and cisplatin with granulocyte colony-stimulating factor: neuromuscular toxicity is dose-limiting. [electronic resource]
Producer: 19931105Description: 2010-20 p. digitalISSN:- 0732-183X
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Bone Marrow Diseases -- chemically induced
- Cisplatin -- administration & dosage
- Dose-Response Relationship, Drug
- Female
- Granulocyte Colony-Stimulating Factor -- therapeutic use
- Humans
- Least-Squares Analysis
- Male
- Middle Aged
- Neoplasms -- drug therapy
- Neuromuscular Diseases -- chemically induced
- Paclitaxel -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.